Intuitive Surgical (NASDAQ:ISRG) SVP Mark Brosius Sells 4,500 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 4,500 shares of Intuitive Surgical stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00. Following the completion of the transaction, the senior vice president directly owned 907 shares in the company, valued at $496,455.52. This represents a 83.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Mark Brosius also recently made the following trade(s):

• On Monday, December 15th, Mark Brosius sold 464 shares of Intuitive Surgical stock. The stock was sold at an average price of $548.49, for a total transaction of $254,499.36.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $559.52 on Tuesday. The firm has a market capitalization of $200.58 billion, a price-to-earnings ratio of 74.01, a PEG ratio of 4.98 and a beta of 1.68. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The company’s 50 day moving average price is $531.81 and its 200 day moving average price is $505.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the previous year, the firm earned $1.84 earnings per share. Intuitive Surgical’s revenue for the quarter was up 22.9% on a year-over-year basis. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ISRG. Piper Sandler increased their price target on Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Mizuho set a $575.00 target price on Intuitive Surgical in a research note on Wednesday, October 22nd. HSBC raised their target price on Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Leerink Partners upped their price target on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Finally, Robert W. Baird set a $655.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $608.79.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. Tobam raised its stake in shares of Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares in the last quarter. Kilter Group LLC acquired a new position in Intuitive Surgical during the 2nd quarter valued at about $27,000. Princeton Global Asset Management LLC bought a new stake in shares of Intuitive Surgical during the 2nd quarter worth about $30,000. TD Capital Management LLC raised its position in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 45 shares in the last quarter. Finally, Greykasell Wealth Strategies Inc. acquired a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $27,000. 83.64% of the stock is currently owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.